Overall, these studies are the first to demonstrate that Willin/FRMD6 can affect mitochondrial structure and function and furthermore that expression of Willin/FRMD6 is altered by Aβ and oxidative stress; thus, we provide novel avenues for future investigation into the role of Willin/FRMD6 as an AD risk gene. This evidence concerns the gene FRMD6 and Alzheimer disease.